Dilated cardiomyopathy trials in Japan

1 trial · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  Endocardial Delivery for Myocardial Regeneration Using Allogeneic iPSC-derived Cardiomyocyte Spheroids for HF With Systolic Dysfunction (EMERALD Study)

  Where

  Kawasaki, Matsumoto, Shinagawa Ku, Shinjuku-ku, Tsukuba

  Age

  20 years to 80 years

  People

  14

  Run by

  Heartseed Inc.

  See details and how to joinNCT07347197